Paul C. Keelan1, Abhiram Prasad, Gregory W. Barsness
1Cardiac Catheterization Laboratory, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. barsness.gregory@mayo.edu
Angiotensin converting enzyme (ACE) inhibitors offer cardiac and vascular protection for patients after coronary revascularization. These drugs improve endothelial function by blocking angiotensin II and increasing nitric oxide availability.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: